A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients

Transplantation

Volumn 74, Issue 7, 2002, Pages 961-966

  Offner, Gisela ^a   Broyer, Michel ^b   Niaudet, Patrick ^b   Loirat, Chantal ^c   Mentser, Mark ^d   Lemire, Jacques ^e   Crocker, John F S ^f   Cochat, Pierre ^g   Clark, Godfrey ^h   Chodoff, Lawrence ⁱ   Korn, Alexander ⁱ   Hall, Michael ⁱ  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f IWK HEALTH CENTRE   (Canada)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h GUY S HOSPITAL   (United Kingdom)

ⁱ NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY;

ADOLESCENT; ARTICLE; BOLUS INJECTION; CADAVER KIDNEY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; GRAFT REJECTION; HLA MATCHING; HUMAN; HYPERTENSION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PULSE RATE; RHINITIS; SEPSIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

EID: 0037108858     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200210150-00010     Document Type: Article

References (14)

1. Nashan B, Moore R, Amlot P, et al. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. Lancet 1997;350:1193-1198.
2. Kahan BD, Rajagopalan PR, Hall M. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. Transplantation 1999;67:276-284.
3. Almond PS, Matas AJ, Gillingham K, et al. Pediatric renal transplants: results with sequential immunosuppression. Transplantation 1992;53(1):46-51.
4. Wolff G, Strecker K, Vester U, et al. Non-compliance following renal transplantation in children and adolescents. Pediatr Nephrol 1998; 12(9):703-708.
5. Matas AJ, Gillingham KJ, Chavers BM, et al. The importance of early cyclosporine levels in pediatric kidney transplantation. Clin Transplant 1996;10(6 Pt 1):482-486.
6. Singh A, Stablein D, Tejani A. Risk factors for vascular thrombosis in pediatric renal transplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1997; 63(9):1263-1267.
7. Novartis Pharmaceuticals Corporation. Neoral Package Insert. March, 1998.
8. Tejani AH, Sullivan EK, Harmon WE, et al. Pediatric renal transplantation: the NAPRTCS experience. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1997. Los Angeles, Regents of the University of California 1998, pp 87-100.
9. Anon. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2001 Annual Report.
10. Tejani A, Harmon W, Benfield M, et al. A randomized, prospective, multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation. Transplantation 2000;69(8):S111
11. Cohn RA, Sherbotie JR, Grimm PC, et al. Basiliximab (Simulect) dramatically reduces acute rejection after pediatric kidney transplantation. Transplantation 2000;69(8):S260.
12. Cecka JM, Gjertson DW, Terasaki PI. Pediatric renal transplantation. A review of the UNOS data. United Network for Organ Sharing. Pediatr Transplant 1997;1(1):55-64.
13. Chavers BM, Gillingham KJ, Matas AJ, Complications by age in primary pediatric renal transplant recipients. Pediatr Nephrol 1997;11(4):399-403.
14. Vester U, Kranz, B, Testa G, et al. Efficacy and tolerability of interleukin-2 receptor blockade with basiliximab in pediatric renal transplant recipients. Pediatr Transplant 2001;5:297-301.